181 related articles for article (PubMed ID: 33617806)
1. The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With Bronchiectasis.
Metersky ML; Choate R;
Chest; 2021 Aug; 160(2):466-469. PubMed ID: 33617806
[No Abstract] [Full Text] [Related]
2. A Woman with a 15-Year History of Bronchiectasis and Recurrent Nontuberculous Mycobacterium Pulmonary Disease.
Hogan PE; Koelsch T; Daley CL; Kasperbauer SH
Ann Am Thorac Soc; 2018 Mar; 15(3):380-382. PubMed ID: 29493335
[No Abstract] [Full Text] [Related]
3. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.
Henkle E; Aksamit TR; Barker AF; Curtis JR; Daley CL; Anne Daniels ML; DiMango A; Eden E; Fennelly K; Griffith DE; Johnson M; Knowles MR; Leitman A; Leitman P; Malanga E; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Prieto D; Salathe M; Thomashow B; Tino G; Turino G; Wisclenny S; Winthrop KL
Chest; 2017 Dec; 152(6):1120-1127. PubMed ID: 28479113
[TBL] [Abstract][Full Text] [Related]
4. Bronchial wash culture is less valuable in patients suspected to have nontuberculous mycobacteria lung disease for bilateral bronchiectasis with nodules.
Watanabe K; Shinkai M; Shinoda M; Kaneko T
Int J Mycobacteriol; 2018; 7(2):178-182. PubMed ID: 29900897
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of bronchiectasis in patients with Marfan syndrome.
Hwang HS; Yi CA; Yoo H; Yang JH; Kim DK; Koh WJ
Int J Tuberc Lung Dis; 2014 Aug; 18(8):995-7. PubMed ID: 25199019
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacterial disease managed within UK primary care, 2006-2016.
Axson EL; Bloom CI; Quint JK
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1795-1803. PubMed ID: 29951934
[TBL] [Abstract][Full Text] [Related]
8. Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease.
Koh WJ; Jeong BH; Jeon K; Kim SY; Park KU; Park HY; Huh HJ; Ki CS; Lee NY; Lee SH; Kim CK; Daley CL; Shin SJ; Kim H; Kwon OJ
Chest; 2016 Dec; 150(6):1211-1221. PubMed ID: 27167209
[TBL] [Abstract][Full Text] [Related]
9. Radiologic types of Mycobacterium xenopi pulmonary disease: different patients with similar short-term outcomes.
Hirama T; Brode SK; Marras TK
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):373-381. PubMed ID: 30552538
[TBL] [Abstract][Full Text] [Related]
10. Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis.
Mirsaeidi M; Sadikot RT
Int J Mycobacteriol; 2015 Jun; 4(2):92-6. PubMed ID: 26097805
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
[TBL] [Abstract][Full Text] [Related]
13. Nonantibiotic Management of Nontuberculous Mycobacteria in Non-Cystic Fibrosis Bronchiectasis: Natural or Nonsense?
Hisert KB; Nick JA
Ann Am Thorac Soc; 2024 Apr; 21(4):543-545. PubMed ID: 38557420
[No Abstract] [Full Text] [Related]
14. Nontuberculous mycobacteria in diffuse panbronchiolitis.
Tsuji T; Tanaka E; Yasuda I; Nakatsuka Y; Kaji Y; Yasuda T; Hashimoto S; Hwang MH; Hajiro T; Taguchi Y
Respirology; 2015 Jan; 20(1):80-6. PubMed ID: 25269823
[TBL] [Abstract][Full Text] [Related]
15. [MYCOBACTERIUM ABSCESSUS PULMONARY DISEASE: IMPORTANT PATHOGEN INVOLVED IN MICROBIAL SUBSTITUTION DURING THE TREATMENT OF NON-ABSCESSUS MYCOBACTERIAL DISEASE].
Tsunoda Y; Sekine A; Sumazaki Y; Tanaka T; Lin SY; Takoi H; Hayashihara K; Moriya A; Saito T
Kekkaku; 2016 Apr; 91(4):469-73. PubMed ID: 27530020
[TBL] [Abstract][Full Text] [Related]
16. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.
Marras TK; Mehta M; Chedore P; May K; Al Houqani M; Jamieson F
Lung; 2010 Aug; 188(4):289-99. PubMed ID: 20383715
[TBL] [Abstract][Full Text] [Related]
17. Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment.
Yoon HJ; Chung MJ; Koh WJ; Jhun BW; Moon SM
Medicine (Baltimore); 2019 Sep; 98(36):e16826. PubMed ID: 31490369
[TBL] [Abstract][Full Text] [Related]
18. The association between computed tomography scan findings of pulmonary infection caused by atypical mycobacteria and bacillus count in sputum samples.
Mehrian P; Farnia P; Karamad M
Int J Mycobacteriol; 2018; 7(4):355-357. PubMed ID: 30531034
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
Binder AM; Adjemian J; Olivier KN; Prevots DR
Am J Respir Crit Care Med; 2013 Oct; 188(7):807-12. PubMed ID: 23927602
[TBL] [Abstract][Full Text] [Related]
20. Nontuberculous mycobacteria in the setting of cystic fibrosis.
Ebert DL; Olivier KN
Clin Chest Med; 2002 Sep; 23(3):655-63. PubMed ID: 12371001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
